AI Insight
Researchers developed a hierarchical nanostructure combining zinc-iron layered double hydroxide (ZnFe-LDH) with manganese dioxide (MnO₂) for the electrochemical detection of lenalidomide, an immunomodulatory drug used in cancer treatment. The composite material demonstrated enhanced sensitivity in voltammetric measurements due to its high surface area, improved electrical conductivity, and synergistic effects between the two components. The sensor showed good selectivity, reproducibility, and a wide linear detection range for lenalidomide quantification.
Why it matters
This advancement enables more accurate and efficient monitoring of lenalidomide levels in pharmaceutical formulations and potentially in biological samples, which is crucial for ensuring proper dosing in cancer patients and maintaining drug quality control. The methodology could be adapted for detecting other pharmaceutical compounds, offering a cost-effective alternative to traditional chromatographic techniques.
Understand the Science